10 companies

WuXi XDC Cayman

Market Cap: HK$66.6b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

2268

HK$52.95

7D

-2.1%

1Y

24.0%

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$35.3b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

2315

HK$51.80

7D

-4.5%

1Y

228.7%

RemeGen

Market Cap: HK$65.8b

A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.

9995

HK$93.20

7D

5.0%

1Y

370.2%

CanSino Biologics

Market Cap: HK$13.7b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

6185

HK$33.16

7D

-0.9%

1Y

-2.6%

Consun Pharmaceutical Group

Market Cap: HK$13.7b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

1681

HK$16.27

7D

-5.8%

1Y

86.4%

JBM (Healthcare)

Market Cap: HK$2.2b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

2161

HK$2.65

7D

-4.0%

1Y

47.2%

Innovent Biologics

Market Cap: HK$140.6b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

1801

HK$81.05

7D

0.2%

1Y

99.6%

Luye Pharma Group

Market Cap: HK$9.4b

Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.

2186

HK$2.36

7D

-2.9%

1Y

0.9%

China Medical System Holdings

Market Cap: HK$32.7b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

New

867

HK$13.49

7D

6.1%

1Y

76.3%

Simcere Pharmaceutical Group

Market Cap: HK$29.8b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

2096

HK$11.52

7D

-0.09%

1Y

47.9%